These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


763 related items for PubMed ID: 18250181

  • 1. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE.
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 3. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
    Jensen D, Alsuhail A, Viola R, Dudgeon DJ, Webb KA, O'Donnell DE.
    J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
    Guenette JA, Raghavan N, Harris-McAllister V, Preston ME, Webb KA, O'Donnell DE.
    Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
    Peters MM, Webb KA, O'Donnell DE.
    Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease.
    Ong KC, Kor AC, Chong WF, Earnest A, Wang YT.
    Am J Respir Crit Care Med; 2004 May 01; 169(9):1028-33. PubMed ID: 14977622
    [Abstract] [Full Text] [Related]

  • 11. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C, King GG, Berend N, Salome CM.
    Respir Med; 2011 Sep 01; 105(9):1345-51. PubMed ID: 21482091
    [Abstract] [Full Text] [Related]

  • 12. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease.
    Stevenson NJ, Calverley PM.
    Thorax; 2004 Aug 01; 59(8):668-72. PubMed ID: 15282386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE.
    Am J Respir Crit Care Med; 2008 Mar 15; 177(6):622-9. PubMed ID: 18006885
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease.
    Mainguy V, Girard D, Maltais F, Saey D, Milot J, Sénéchal M, Poirier P, Provencher S.
    Am J Cardiol; 2012 Jul 15; 110(2):258-63. PubMed ID: 22497677
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.